Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Blink Boost

Last content change checked dailysee data sync status

Active ingredient
Glycerin 5 mg/1 mL
Other brand names
Drug class
Non-Standardized Chemical Allergen
Dosage form
Solution/ Drops
Route
Ophthalmic
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2025
Label revision date
February 25, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Glycerin 5 mg/1 mL
Other brand names
Drug class
Non-Standardized Chemical Allergen
Dosage form
Solution/ Drops
Route
Ophthalmic
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2025
Label revision date
February 25, 2025
Manufacturer
Bausch & Lomb Incorporated
Registration number
M018
NDC root
29943-007
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to provide temporary relief from burning and irritation caused by dryness of the eye. It can also help alleviate discomfort from minor irritations, such as those resulting from exposure to wind or sun. Additionally, it acts as a protectant against further irritation and helps to relieve dryness in the eyes, making it a supportive option for maintaining eye comfort.

Uses

If you're experiencing burning or irritation from dry eyes, this product can provide temporary relief. It’s also helpful if your eyes feel uncomfortable due to minor irritations or exposure to wind or sun. Additionally, it acts as a protectant, helping to prevent further irritation and relieve dryness in your eyes.

Dosage and Administration

To use your eye drops, start by removing the tamper-evident ring and then take off the cap. Hold the bottle at a downward angle or even upside down to help deliver the drops directly into your eye. Gently squeeze the bottle to release 1 or 2 drops into the affected eye or eyes as needed. After you’re done, make sure to replace the cap securely to keep the drops safe for future use.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where the body becomes reliant on a substance).

Since there are no explicit "do not take" or "do not use" instructions, it suggests that this medication is generally safe for use. However, always consult with your healthcare provider for personalized advice and to ensure it’s appropriate for your individual health needs.

Side Effects

When using this product, it's important to be aware of potential side effects. You should stop using it and consult a doctor if you experience eye pain, changes in your vision, or if redness or irritation in your eye continues. Additionally, if your condition worsens or does not improve after 72 hours, seek medical advice.

Remember, this product is for external use only. Do not use it if the solution has changed color or become cloudy, or if the tamper-evident ring is broken or missing. To avoid contamination, do not touch the tip of the container to any surface, and always replace the cap after use.

Warnings and Precautions

This product is for external use only. Please do not use it if the solution has changed color or become cloudy, or if the tamper-evident ring is broken or missing. While using the product, avoid touching the tip of the container to any surface to prevent contamination, and remember to replace the cap after each use.

If you experience eye pain, changes in vision, or if redness or irritation of the eye continues, stop using the product and consult your doctor. Additionally, if your condition worsens or does not improve within 72 hours, seek medical advice.

In case of accidental swallowing, it is important to get emergency medical help or contact a Poison Control Center immediately.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to err on the side of caution when it comes to your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no specific information available about the use of this medication during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions have not been established.

Before taking any medication, including this one, you should consult with your healthcare provider to discuss potential risks and benefits. They can help you make informed decisions that prioritize your health and the health of your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or considerations mentioned regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. Always consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child swallows any of it, seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual safety considerations and monitoring practices for patients with renal impairment (kidney issues) are not detailed.

It's always best to consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can provide guidance tailored to your specific situation.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that your treatment is safe and effective based on your individual health needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use alongside other treatments and tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you. Always feel free to ask questions or express any concerns you may have regarding your medications or tests.

Storage and Handling

To ensure the best performance and safety of your product, store it at a temperature between 15–25 °C (59–77 °F). This temperature range helps maintain the integrity of the device.

When handling the product, be sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

You will use this medication in your eyes, specifically through an ophthalmic (eye) route. To apply it, simply use a squeeze bottle to instill 1 or 2 drops into the affected eye(s) as needed. There are no additional details regarding laboratory tests, abuse potential, or patient counseling information available at this time.

FAQ

What is the purpose of this eye drop medication?

This medication is for the temporary relief of burning and irritation due to dryness of the eye, as well as discomfort from minor irritations or exposure to wind or sun.

How should I use this eye drop medication?

Remove the tamper evident ring and cap, then tip the bottle at a downward angle or upside down. Squeeze the bottle to instill 1 or 2 drops in the affected eye(s) as needed, and replace the cap after use.

Are there any warnings I should be aware of?

Yes, this product is for external use only. Do not use if the solution changes color or becomes cloudy, or if the tamper evident ring is broken or missing.

When should I stop using this medication and consult a doctor?

You should stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation, or if the condition worsens or persists for more than 72 hours.

What should I do if I accidentally swallow this medication?

If swallowed, get medical help or contact a Poison Control Center right away.

Is this medication safe for children?

Keep this medication out of reach of children.

What are the storage conditions for this medication?

Store the medication at 15–25 °C (59–77 °F).

Packaging Info

Below are the non-prescription pack sizes of Blink Boost (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blink Boost.
Details

Drug Information (PDF)

This file contains official product information for Blink Boost, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation due to dryness of the eye. It is also indicated for the temporary relief of discomfort resulting from minor irritations of the eye or exposure to environmental factors such as wind or sun. Additionally, this drug serves as a protectant against further irritation and aids in relieving dryness of the eye.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to remove the tamper-evident ring before taking off the cap of the bottle. The bottle should be tipped at a downward angle or held upside down to facilitate the delivery of the drop to the eye. Patients are to squeeze the bottle gently to instill 1 or 2 drops into the affected eye(s) as needed. After use, it is essential to replace the cap securely to maintain the integrity of the product.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

The product is intended for external use only. It is imperative that healthcare professionals advise patients not to use the solution if there are any changes in color or if the solution becomes cloudy. Additionally, the product should not be used if the tamper-evident ring is broken or missing, as this may indicate contamination or compromise of the product's integrity.

When administering this product, it is crucial to avoid contact between the tip of the container and any surface to prevent contamination. After each use, the cap should be securely replaced to maintain the sterility of the solution.

Patients should be instructed to discontinue use and consult a healthcare provider if they experience any of the following symptoms: eye pain, changes in vision, or persistent redness or irritation of the eye. If the condition worsens or does not improve within 72 hours, medical advice should be sought.

In the event of accidental ingestion, immediate medical assistance should be obtained, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated for use if the solution changes color or becomes cloudy, or if the tamper evident ring is broken or missing.

During the use of this product, patients are advised to avoid touching the tip of the container to any surface to prevent contamination and to ensure the cap is replaced after each use.

Patients should discontinue use and consult a doctor if they experience any of the following adverse reactions: eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Blink Boost (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blink Boost.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of established safety data in pregnancy and the importance of discussing any plans for pregnancy or breastfeeding with their healthcare provider.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, as with any medication, it is advisable to monitor breastfed infants for any potential adverse effects.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of specific guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients that if the medication is swallowed, it is crucial to seek medical help or contact a Poison Control Center immediately. This information is vital for ensuring patient safety and prompt action in case of accidental ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15–25 °C (59–77 °F) to maintain its integrity and efficacy. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment. Special handling needs must be observed to prevent any compromise to the product's quality.

Additional Clinical Information

The route of administration for the medication is ophthalmic, utilizing a squeeze bottle to instill 1 or 2 drops in the affected eye(s) as needed. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Blink Boost, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Blink Boost, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.